Total plasma homocysteine measurement: Evaluation of the Abbott immunoassay, comparison with the JEOL ion exchange chromatography and investigation of its clinical utility

por Suen, Kai Fung Kevin, Lee, Graham R., Finnegan, Michelle, Halton, Kieran, Borovickova, Ingrid, Trench, Caoilfionn, Fitzgibbon, Maria C.
Publicado 2022

Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis

por Blumenfeld, Andrew M., Goadsby, Peter J., Dodick, David W., Hutchinson, Susan, Liu, Chengcheng, Finnegan, Michelle, Trugman, Joel M., Szegedi, Armin
Publicado 2021

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial

por Ashina, Messoud, Tepper, Stewart J., Reuter, Uwe, Blumenfeld, Andrew M., Hutchinson, Susan, Xia, Jing, Miceli, Rosa, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M.
Publicado 2023

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

por Ailani, Jessica, Lipton, Richard B., Hutchinson, Susan, Knievel, Kerry, Lu, Kaifeng, Butler, Matthew, Yu, Sung Yun, Finnegan, Michelle, Severt, Lawrence, Trugman, Joel M.
Publicado 2020

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults

por Goadsby, Peter J, Tepper, Stewart J, Watkins, Paul B, Ayele, Girma, Miceli, Rosa, Butler, Matthew, Severt, Lawrence, Finnegan, Michelle, Szegedi, Armin, Trugman, Joel M, Jakate, Abhijeet
Publicado 2019

Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain

por Lipton, Richard B., Dodick, David W., Goadsby, Peter J., Burstein, Rami, Adams, Aubrey M., Lai, Jeff, Yu, Sung Yun, Finnegan, Michelle, Kuang, Amy W., Trugman, Joel M.
Publicado 2022

Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial

por Schwedt, Todd J, Lipton, Richard B, Ailani, Jessica, Silberstein, Stephen D, Tassorelli, Cristina, Guo, Hua, Lu, Kaifeng, Dabruzzo, Brett, Miceli, Rosa, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M
Publicado 2021

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial

por Lipton, Richard B., Pozo-Rosich, Patricia, Blumenfeld, Andrew M., Dodick, David W., McAllister, Peter, Li, Ye, Lu, Kaifeng, Dabruzzo, Brett, Miceli, Rosa, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M.
Publicado 2022